World Finance7y
Pfizer, Glaxo sign 10-year vaccine deal for poor
Glaxo and Pfizer each committed to supply 30 million doses of their Synfloriz and Prevnar vaccines to GAVI over 10 years, at $7 per dose for the first 20 percent supplied, dropping to $3.50 for the ...
MarketWatch1mon
GSK settles vast majority of Zantac claims for $2.2 billion
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
Reuters1mon
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
GSK to pay $70 million to settle whistleblower lawsuit Pfizer and Sanofi also settling Zantac cases Boehringer Ingelheim faces trial, denies wrongdoing Oct 9 (Reuters) - GSK (GSK.L), opens new tab ...
pharmaphorum2d
GSK finds synergies with global marketing strategy
GSK has shifted towards a global marketing model influenced by a Netflix-style approach that aims to match content to the person receiving it. Richard Staines heard about this new strategy at the ...
SB Nation on MSN1mon
Gavi comes through practice match as Barca comeback nears
Gavi took another step closer to his long-awaited first-team comeback at Barcelona after coming through a practice match at ...
Investing5d
Glaxo Smith Kline (BIOC)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Smith College6mon
Discover Smith
Knowledge. Community. Generosity. These three concepts capture Smith’s identity as an institution. Since its founding in 1871, Smith has remained at the forefront of higher education. A leader in ...
The Washington Post12d
Glaxo: Q3 Earnings Snapshot
BRENTFORD, Britain — BRENTFORD, Britain — GSK plc (GSK) on Wednesday reported a loss of $75.4 million in its third quarter. The Brentford, Britain-based company said it had a loss of 4 cents ...
Los Angeles Times4y
Karin Klein
Karin Klein is a Los Angeles Times board member who writes editorials about education, environment, food and science. She was the 2006-07 winner of the Eugene C. Pulliam Fellowship for Editorial ...
Smith College3y
Apply to Smith
We’re so glad you’re considering Smith, and we can’t wait to read your application. We carefully consider your high school program, performance, experiences, and potential for success at Smith. When ...
Reuters on MSN1mon
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
(Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued ...
Investing13d
Glaxo Smith Kline (BIOC)
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...